Literature DB >> 18553090

Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

Hiroshige Fujishiro1, Tae-Beom Ahn, Roberta Frigerio, Anthony DelleDonne, Keith A Josephs, Joseph E Parisi, J Eric Ahlskog, Dennis W Dickson.   

Abstract

In this study, we used immunohistochemistry to screen for alpha-synuclein pathology in the brains of 241 individuals without clinical evidence of neurologic disease, and discovered 36 cases (15%) with incidental Lewy bodies (LBs) and one case, a 96-year-old woman (0.4%), with inclusions similar to those seen in multiple system atrophy (MSA), a non-familial neurodegenerative disorder characterized by parkinsonism, cerebellar ataxia and autonomic dysfunction and alpha-synuclein immunoreactive glial cytoplasmic inclusions (GCI). In a routine hospital autopsy series of 125 brains, we detected GCI in a neurologically normal 82-year-old man (0.8%). Both cases showed widespread GCI in the central nervous system, as well as a few neuronal cytoplasmic inclusions, but no neuronal loss or gliosis in vulnerable brain regions, including the substantia nigra, putamen, inferior olive and pontine base. Applying a recently proposed grading scale for MSA, the two cases showed pathology far below that detected in patients with clinically overt MSA, suggesting the possibility that these two individuals had preclinical MSA. The prevalence of clinically overt MSA is estimated to be about 4 per 100,000 persons (0.004%), which is far less than the frequency of GCI in this series (0.4-0.8%). Further studies are needed to determine if GCI in neurologically normal elderly represents prodromal MSA or a rare non-progressive age-related alpha-synucleinopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553090      PMCID: PMC2880173          DOI: 10.1007/s00401-008-0398-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.

Authors:  A Schrag; Y Ben-Shlomo; N P Quinn
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

2.  Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell.

Authors:  H W Berendse; J Booij; C M Francot; P L Bergmans; R Hijman; J C Stoof; E C Wolters
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

3.  Frequency of bowel movements and the future risk of Parkinson's disease.

Authors:  R D Abbott; H Petrovitch; L R White; K H Masaki; C M Tanner; J D Curb; A Grandinetti; P L Blanchette; J S Popper; G W Ross
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

Review 4.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

5.  Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E.

Authors:  Takashi Togo; Natalie Cookson; Dennis W Dickson
Journal:  Brain Pathol       Date:  2002-01       Impact factor: 6.508

Review 6.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

Authors:  Hirohisa Watanabe; Yufuko Saito; Shinichi Terao; Tetsuo Ando; Teruhiko Kachi; Eiichiro Mukai; Ikuko Aiba; Yuji Abe; Akiko Tamakoshi; Manabu Doyu; Masaaki Hirayama; Gen Sobue
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

7.  Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.

Authors:  K Gwinn-Hardy; N D Mehta; M Farrer; D Maraganore; M Muenter; S H Yen; J Hardy; D W Dickson
Journal:  Acta Neuropathol       Date:  2000-06       Impact factor: 17.088

8.  Olfactory bulb in multiple system atrophy.

Authors:  Tibor Kovács; Mátyás I Papp; Nigel J Cairns; M Nadeem Khan; Peter L Lantos
Journal:  Mov Disord       Date:  2003-08       Impact factor: 10.338

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 10.  Multiple system atrophy.

Authors:  Gregor K Wenning; Carlo Colosimo; Felix Geser; Werner Poewe
Journal:  Lancet Neurol       Date:  2004-02       Impact factor: 44.182

View more
  23 in total

Review 1.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

2.  "Minimal change" multiple system atrophy with limbic-predominant α-synuclein pathology.

Authors:  Shunsuke Koga; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2018-08-20       Impact factor: 17.088

3.  Non-motor multiple system atrophy associated with sudden death: pathological observations of autonomic nuclei.

Authors:  Yuichi Riku; Hirohisa Watanabe; Maya Mimuro; Yasushi Iwasaki; Mizuki Ito; Masahisa Katsuno; Gen Sobue; Mari Yoshida
Journal:  J Neurol       Date:  2017-09-22       Impact factor: 4.849

4.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

5.  Characterizing Lewy Pathology in 231 Essential Tremor Brains From the Essential Tremor Centralized Brain Repository.

Authors:  Elan D Louis; Daniella Iglesias-Hernandez; Nora C Hernandez; Xena Flowers; Sheng-Han Kuo; Jean Paul G Vonsattel; Phyllis L Faust
Journal:  J Neuropathol Exp Neurol       Date:  2022-09-19       Impact factor: 3.148

Review 6.  Parkinson's disease and parkinsonism: neuropathology.

Authors:  Dennis W Dickson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.

Authors:  Naomi Kouri; Kenichi Oshima; Makio Takahashi; Melissa E Murray; Zeshan Ahmed; Joseph E Parisi; Shu-Hui C Yen; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

Review 8.  The Synucleinopathies: Twenty Years On.

Authors:  Michel Goedert; Ross Jakes; Maria Grazia Spillantini
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

9.  Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent.

Authors:  Devika P Bagchi; Lihai Yu; Joel S Perlmutter; Jinbin Xu; Robert H Mach; Zhude Tu; Paul T Kotzbauer
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.

Authors:  Atsushi Umemura; Tomoko Oeda; Ryutaro Hayashi; Satoshi Tomita; Masayuki Kohsaka; Kenji Yamamoto; Hideyuki Sawada
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.